Skip to Content
Merck

Skip To

V6758

VEGF Receptor-2 (Flk-1, KDR)/Fc Chimera human

>90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder

Synonym(s):

Vascular Endothelial Growth Factor Receptor‑2

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Size/SKUAvailabilityPrice
50 μg
Please contact Customer Service for Availability
CZK 17,100.00

About This Item

UNSPSC Code:
51111800
NACRES:
NA.32
MDL number:
Form:
lyophilized powder
Assay:
>90% (SDS-PAGE)
Biological source:
human
Recombinant:
expressed in NSO cells
Mol wt:
predicted mol wt ~110 kDa

CZK 17,100.00


Please contact Customer Service for Availability

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

human

Quality Segment

recombinant

expressed in NSO cells

assay

>90% (SDS-PAGE)

form

lyophilized powder

potency

10-40 ng/mL ED50

mol wt

predicted mol wt ~110 kDa

packaging

pkg of 50 μg

storage condition

avoid repeated freeze/thaw cycles

impurities

endotoxin, tested

UniProt accession no.

storage temp.

−20°C

Gene Information

human ... KDR(3791)

Application

VEGF Receptor-2 (Flk-1, KDR)/Fc Chimera human is a homodimeric protein contains extracellular domain of human VEGF R2 (KDR) fused to the 6x histidine tagged Fc portion of human IgG1 by the peptide (EGF). The product was used to stuyd vasculogenesis and angiogenesis and as marker for pluripotent hematopoietic stem cells.[1]

Biochem/physiol Actions

VEGF Receptor-2 (VEGF R2) also known as Flk-1 or KDR belongs to class III subfamily of RTKs is a potent VEGF antagonist and is mainly expressed in endothelial cells. VEGF R2 can stimulate PLC-gamma pathway which in turn activate MAP kinase and subsequent strong signalling as well as can partly induces mitotic signals in NIH3T3 fibroblasts.[2] KDR also facilitates the release of nitric oxide in endothelial cells and assist in the regulation of the vasculature.[3]
VEGF receptors, class III receptor tyrosine kinases, have seven Ig like extracellular motifs and a tyrosine kinase intracellular domain split by a kinase insert sequence. VEGFR 1 and 2 are both expressed in an endothelial cell-specific manner.

Physical form

Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline containing 2.5 mg bovine serum albumin.

Analysis Note

The biological activity is measured by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
V1385SRP4633SRP3185
assay

>90% (SDS-PAGE)

assay

>90% (SDS-PAGE)

assay

≥90% (SDS-PAGE)

assay

≥95% (HPLC), ≥95% (SDS-PAGE)

biological source

human

biological source

human

biological source

human

biological source

human

recombinant

expressed in NSO cells

recombinant

expressed in baculovirus infected Sf21 cells

recombinant

expressed in E. coli

recombinant

expressed in HEK 293 cells

form

lyophilized powder

form

lyophilized powder

form

lyophilized

form

lyophilized

mol wt

predicted mol wt ~110 kDa

mol wt

predicted mol wt ~100 kDa

mol wt

15-16 kDa

mol wt

20.0-22.0 kDa

UniProt accession no.

P35968

UniProt accession no.

P17948

UniProt accession no.

-

UniProt accession no.

O43915


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Questions

Reviews

No rating value

Active Filters